Development and validation of a quality-of-life scale for Chinese patients with benign prostatic hyperplasia

BJU International

Volumn 94, Issue 6, 2004, Pages 837-844

  Shi, Jingcheng ^a   Sun, Zhenqiu ^a,b   Cai, Taisheng ^a   Yang, Louyan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Benign prostatic hyperplasia; Quality of life; Reliability; Scale; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CHINESE; CLINICAL PRACTICE; CORRELATION COEFFICIENT; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SHORT FORM 36; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

AGED; CHINA; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 8144227339     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.05043.x     Document Type: Article

References (17)

1. Verdamme KNC, Dieleman JP, Bleumink GS, Van Der Lei J, Sturkenboom MCJM. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care - the triumph project. Eur Urol 2002; 42: 323-8
2. McConnell JD. Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. In Walsh PC, Retik AB, Vaughan ED, Wein AJ eds. Campbell's Urology. 7th edn. Philadelphia: WB Saunders, 1998: 1429
3. Fangliu Gu. Epidemiological survey of benign prostatic hyperplasia and prostate cancer in China. J Beijing Med University 2000; 32: 30-3
4. Van Venrooij GE, Eckhardt MD, Gisolf KW et al. Data from frequency-volume charts versus symptom scores and quality of life score in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2001; 39: 42-7
5. Boyle P. Cultural and linguistic validation of questionnaires for use in international studies: the nine-item BPH-specific quality-of-life scale. Eur Urol 1997; 32 (Suppl. 2): 50-2
6. Michael JB. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. Urology 2001; 58: 25-32
7. Hansen BJ, Flyger H, Brasso K et al. Validation of the self administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol 1995; 76: 451-8
8. Donovan JL, Peters TJ, Abrams P, Brookes ST, de la Rosette JJMCH, Schafer W. Scoring the short form ICSmale-SF questionnaire. (International Continence Society). J Urol 2000; 164: 1948-55
9. Lamping DL, Rowe P, Black N, Lessof L. Development and validation of an audit instrument: the Prostate Outcomes Questionnaire. Br J Urol 1998; 82: 49-62
10. Robert SE, Patricia AD, Christopher GC et al. Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol 1992; 45: 1431-45
11. Yong Yang Fangliu Gu. The recommendations of the Fourth International Consultation on Benign Prostatic Hyperplasia (1998). Chinese J Urol 1998; 19: 752-68
12. Jiqian Fang. The methods and applying of quality of life measurement. Beijing: Beijing Medical University Press, 2000: 263-7
13. Eri LM, Tveter KJ. Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients. Eur Urol 1992; 21: 257-62
14. Skevington SM. Advancing cross-cultural research on quality of life: Observations drawn from the WHO-QOL development. Qual Life Res 2002; 11: 135-44
15. Zhaojie Liu. Evaluation of reliability and validity of the questionnaire. Chinese J Prevention Control Chronic Non-Communicable Dis 1997; 5: 174-7
16. Zhenqiu Sun. Medical Statistics. Beijing: People's Medical Publishing House, 2002: 395-402
17. Saunas AS. Quality of life of patients on the waiting list for benign prostatic hyperplasia surgery. Qual Life Res 2001; 10: 543-53